Literature DB >> 10462028

Biopsy-proven cardiomyopathy in heterozygous Fabry's disease.

N Koitabashi1, T Utsugi, R Seki, E Okamoto, Y Sando, Y Kaneko, R Nagai.   

Abstract

A 23-year-old woman with heterozygous Fabry's disease who had acroparesthesia was admitted to hospital for precise examination of the disease before childbearing. She had no cardiac-related symptoms and no abnormality on physical examination. The alpha-galactosidase A activity in her leukocytes was present, but lower than normal. However, the endomyocardial biopsy showed specific changes for Fabry's disease. As Fabry's disease is a rare X-linked recessive inborn error of glycosphingolipid metabolism, heterozygous females are usually asymptomatic, but rarely can be affected as severely as hemizygous males. This is an isolated case of heterozygous Fabry's disease in a female in whom cardiac involvement was detected by endomyocardial biopsy, although she had no cardiac abnormality on physiological examinations. In conclusion, endomyocardial biopsy is useful for evaluation of the cardiac involvement of Fabry's disease even in an asymptomatic case.

Entities:  

Mesh:

Year:  1999        PMID: 10462028     DOI: 10.1253/jcj.63.572

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  3 in total

Review 1.  An approach to endomyocardial biopsy interpretation.

Authors:  K S Cunningham; J P Veinot; J Butany
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

Authors:  C Whybra; C Kampmann; I Willers; J Davies; B Winchester; J Kriegsmann; K Brühl; A Gal; S Bunge; M Beck
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

3.  Fabry Disease Presenting with Hypertrophic Cardiomyopathy and Tricuspid Regurgitation.

Authors:  Sang-Cheol Cho; Han-Wook Yoo; Jae Won Lee; Jeong Yoon Jang; Ran Heo; Jong-Min Song
Journal:  J Cardiovasc Ultrasound       Date:  2016-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.